tradingkey.logo

United Therapeutics Corp <UTHR.OQ> expected to post earnings of $6.31 a share - Earnings Preview

ReutersFeb 24, 2025 1:54 PM
  • United Therapeutics Corp UTHR.OQ UTHR.O is expected to show a rise in quarterly revenue when it reports results on February 26 for the period ending December 31 2024

  • The Silver Spring Maryland-based company is expected to report a 19.5% increase in revenue to $734.74 million from $614.7 million a year ago, according to the mean estimate from 11 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for United Therapeutics Corp is for earnings of $6.31 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for United Therapeutics Corp is $395.00​, above​ its last closing price of $361.10. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

6.32

6.42

6.39

Missed

-0.5

Jun. 30 2024

6.48

6.40

5.85

Missed

-8.6

Mar. 31 2024

5.70

5.65

6.17

Beat

9.2​

Dec. 31 2023

4.09

4.19

4.36

Beat

4.2

​​Sep. 30 2023

5.04

5.04

5.38

Beat

6.7

Jun. 30 2023

4.49

4.51

5.24

Beat

16.3​

Mar. 31 2023

4.41

4.52

4.86

Beat

7.4

Dec. 31 2022

4.54

4.51

2.67

Missed

-40.8

This summary was machine generated February 24 at 13:54 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI